title: FDA proposes changes in access and charges for experimental drugs.
authors.forename: Bob
authors.initials: B
authors.lastname: Roehr
mesh_terms: D017277:Drug Approval; D005249:Fees and Charges; D004364:Pharmaceutical Preparations / Q000191:economics / Q000600:supply & distribution*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations